An Official Website of the United States Government
Company Information:
Name:
SOURCE PRODUCTION AND EQUIPMENT COMPANY
Address:
113 TEAL ST
ST. ROSE, LA 70087
ST. ROSE, LA 70087
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Brachytherapy Delivery System for Treatment of Lung Cancer
Award Year / Program / Phase:
2007 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John J. Munro
Award Amount:
$100,000.00
Abstract:
DESCRIPTION (provided by applicant): This Phase I program intends to develop an improved brachytherapy delivery system for treatment of lung cancer by incorporating radioactive 169Ytterbium sources into surgical staples used in lung resection. For patients
with compromised cardiopulmonary status,… More
Brachytherapy Delivery System for Treatment of Lung Cancer
Award Year / Program / Phase:
2008 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
John J. Munro
Award Amount:
$750,394.00
Abstract:
DESCRIPTION (provided by applicant): This Phase II program intends to continue to develop an improved brachytherapy delivery system for treatment of lung cancer by incorporating radioactive 169Ytterbium sources into surgical staples used in lung resect
ion. For patients with compromised… More
Intensity Modulated Breast Brachytherapy System
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John J. Munro
Award Amount:
$100,000.00
Abstract:
DESCRIPTION (provided by applicant): The overall objective of this Phase I program is to demonstrate the feasibility of delivering intensity modulated breast brachytherapy, permitting balloon-based breast brachytherapy to better conform to patient anatomy,
reduce potential toxicity by reducing skin… More
HDR Brachytherapy for Intraocular Melanoma
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John J. Munro
Award Amount:
$106,801.00
Abstract:
DESCRIPTION (provided by applicant): HDR Brachytherapy for Intraocular Melanoma - Project Summary/Abstract The overall objective of this Phase I program is to develop a brachytherapy system for the treatment of intraocular melanoma that reduces hospitaliza
tion time, provides improved dosimetry to… More